fda warns against semaglutide The of the Risks Using Compounded May Entail FDA warns against using compounded

Circulation (2008) 117(18):234050

While Wegovy is not specifically indicated as a treatment for high blood pressure or high cholesterol, its still fundamentally the same medication as Ozempic (just in higher doses), meaning that it can also help with high blood pressure

Contamination Risks: Expired Semaglutide and Safety Concerns Expired semaglutide can pose significant contamination risks, especially when it is not stored correctly

Canadas certificate of supplementary protection register lists semaglutide with patent 2601784, a March 20, 2026 patent expiry date and a CSP term that would have extended to March 20, 2028